— Know what they know.
Not Investment Advice

TAUG OTC

Tauriga Sciences, Inc.
1W: -90.0% 1M: -90.0% 3M: -90.0% 1Y: -100.0% 3Y: -100.0% 5Y: -100.0%
$0.00
Last traded 2023-08-11 — delisted
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · $2999 mcap · 293M float · 0.0005% daily turnover

Balance Sheet Trends

Total Assets
$2M +286.8% ▲
5Y CAGR: +200.5%
Total Liabilities
$1M +27.9% ▲
5Y CAGR: -12.0%
Shareholders Equity
$1M +512.5% ▲
Cash & Investments
$2M +465.0% ▲
5Y CAGR: +363.7%
Total Debt
$569K -13.5% ▼
5Y CAGR: +15.8%
Net Debt
$520K -20.4% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2017FY2018FY2019FY2020FY2021
— Assets —
Cash$18$12K$386K$5K$50K
Short-Term Investments$625$633K$423K$279K$2M
Cash & ST Investments$643$645K$809K$285K$2M
Net Receivables$0$581-$350$43K$32K
Inventory$0$0$11K$129K$647K
Other Current Assets$2K$41K$128K$152K$131K
Total Current Assets$3K$686K$948K$608K$2M
Property, Plant & Equip.$961$2K$13K$36K$81K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$11K
Total Non-Current Assets$961$2K$13K$36K$92K
Total Assets$4K$689K$961K$643K$2M
— Liabilities —
Accounts Payable$279K$30K$35K$76K$391K
Short-Term Debt$580K$255K$214K$649K$519K
Deferred Revenue$0$0$0$384$0
Other Current Liabilities$1M$39K$209K$217K$257K
Total Current Liabilities$2M$319K$457K$943K$1M
Long-Term Debt$0$0$0$9K$50K
Other Non-Current Liab.$75K$75K$0$0$0
Total Non-Current Liabilities$75K$75K$0$9K$50K
Total Liabilities$2M$394K$457K$952K$1M
— Equity —
Common Stock$17K$523$681$1K$3K
Retained Earnings-$54M-$54M-$55M-$59M-$62M
Accumulated OCI-$240K$8K$0$0$0
Total Stockholders Equity-$2M$297K$503K-$308K$1M
Total Liabilities & Equity$4K$689K$961K$643K$2M
— Key Metrics —
Total Debt$580K$255K$214K$658K$569K
Net Debt$580K$243K-$172K$653K$520K
Total Investments$625$633K$423K$279K$2M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms